MRA Advisory Group
PFE icon

MRA Advisory Group’s Pfizer PFE Stock Holding History

MRA Advisory Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$234K Sell
8,221
-908
-10% -$24.2K 0.09% 127
2026
Q2 		$220K Buy
9,129
+391
+4% +$10.2K 0.08% 132
2026
Q1 		$245K Buy
8,738
+269
+3% +$7.16K 0.1% 116
2025
Q4 		$211K Sell
8,469
-10
-0.1% -$252 0.09% 116
2025
Q3 		$216K Buy
+8,479
New +$209K 0.09% 121
2025
Q2 		– Sell
-9,762
Closed -$247K – 155
2025
Q1 		$247K Sell
9,762
-5,438
-36% -$142K 0.13% 100
2024
Q4 		$403K Sell
15,200
-6,940
-31% -$188K 0.21% 57
2024
Q3 		$641K Sell
22,140
-140
-0.6% -$4.08K 0.35% 37
2024
Q2 		$623K Buy
22,280
+3,970
+22% +$109K 0.36% 34
2024
Q1 		$508K Buy
18,310
+2,132
+13% +$59.2K 0.3% 46
2023
Q4 		$466K Sell
16,178
-639
-4% -$19.3K 0.31% 48
2023
Q3 		$558K Sell
16,817
-3,024
-15% -$107K 0.4% 51
2023
Q2 		$728K Buy
19,841
+461
+2% +$17.9K 0.5% 35
2023
Q1 		$791K Buy
19,380
+2,697
+16% +$116K 0.57% 31
2022
Q4 		$855K Buy
16,683
+476
+3% +$22.8K 0.67% 31
2022
Q3 		$677K Buy
16,207
+141
+0.9% +$6.85K 0.58% 33
2022
Q2 		$842K Sell
16,066
-4,314
-21% -$220K 0.74% 27
2022
Q1 		$1.06M Buy
20,380
+1,151
+6% +$59.7K 0.8% 26
2021
Q4 		$1.14M Sell
19,229
-242
-1% -$12K 0.88% 29
2021
Q3 		$837K Buy
19,471
+596
+3% +$26.4K 0.71% 34
2021
Q2 		$739K Buy
18,875
+1,656
+10% +$64.4K 0.63% 37
2021
Q1 		$624K Buy
17,219
+606
+4% +$21.5K 0.59% 41
2020
Q4 		$612K Buy
+16,613
New +$609K 0.6% 40

Other funds holding PFE

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

MRA Advisory Group's PFE Position: Q3 2026 in Review

MRA Advisory Group reduced its Pfizer (PFE) stake by 9.9% in Q3 2026, selling an estimated $24.2K and leaving 8,221 shares worth $234K. The position accounts for 0.09% of the portfolio, ranked #127.

MRA Advisory Group first reported a position in PFE in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.14M in Q4 2021. 1,268 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • MRA Advisory Group held 8,221 shares of Pfizer worth $234K as of Q3 2026.
  • MRA Advisory Group sold 908 Pfizer shares in Q3 2026, an estimated $24.2K.
  • Pfizer made up 0.09% of MRA Advisory Group's portfolio in Q3 2026, its #127 holding.
  • MRA Advisory Group first reported a position in Pfizer in Q4 2020 and has held it in 23 quarters since.
  • MRA Advisory Group's Pfizer position peaked at $1.14M in Q4 2021.
  • 1,268 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on MRA Advisory Group's 13F filing for Q3 2026, filed 7 Oct 2026.